Trials Offered by a Specific Doctor

HERBERT IRVING COMPREHENSIVE CANCER CENTER
Investigator
Charles Drake, MD
Phone
212-305-2055
Email
cgd2139@cumc.columbia.edu
(Biography not available)

Clinical Studies Managed By Dr. Drake:
More InfoTitleSponsorIRB Number
Details[CLOSED] A study for patients with advanced bladder cancer using study drug MOXR0916Genentech, Inc.AAAR1205
DetailsStudy of BMS-986253 in Combination with Nivolumab in Advanced CancersBristol-Myers SquibbAAAR6272
Details[CLOSED] Study of Study Drug MGD009 in Patients with Prostate CancerMacroGenetics, Inc.AAAR6359
DetailsStudy of Drug Alone and In Combination with Nivolumab in Advanced Solid TumorsBristol-Myers SquibbAAAR2426
DetailsStudy of Antibody Drug in Patients with Advanced Renal Cell CarcinomaBMSAAAR3743
DetailsStudy of Immunotherapy with Nivolumab or BMS-986253 Added to Degarelix in Patients with Prostate Cancer (MAGIC-8)Bristol Myers SquibbAAAR7949
DetailsStudy of a Neoantigen Cancer Vaccine in Patients with Advanced Solid Tumors (Bladder, Colon, Stomach, Lung, Esophageal, or Rectal Cancer)Gritstone OncologyAAAS0000
DetailsStudy of Spartalizumab and Canakinumab Prior to Radical Nephrectomy in Patients with Localized Clear Cell Renal Cell CarcinomaNovartisAAAS2814
DetailsStudy of REGN5678 (Anti-PSMAxCD28) With Cemiplimab (Anti-PD-1) in Patients With Metastatic Castration-resistant Prostate CancerRegeneron PharmaceuticalsAAAS3594
DetailsStudy of AZD4635 in Patients with Prostate CancerAstraZenecaAAAS6539